Pacer Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,426
Closed -$4.68K 2583
2024
Q2
$4.68K Sell
1,426
-1,968
-58% -$6.46K ﹤0.01% 3619
2024
Q1
$24.9K Buy
+3,394
New +$24.9K ﹤0.01% 3399
2021
Q2
Sell
-822
Closed -$68K 1455
2021
Q1
$68K Sell
822
-576
-41% -$47.7K ﹤0.01% 1387
2020
Q4
$127K Sell
1,398
-2,020
-59% -$184K ﹤0.01% 1323
2020
Q3
$137K Buy
+3,418
New +$137K ﹤0.01% 1221
2018
Q4
Sell
-4,378
Closed -$71K 720
2018
Q3
$71K Buy
+4,378
New +$71K ﹤0.01% 1124